A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hendrik Reesink, MD, PhD
Academic Medical Center of the University of Amsterdam
Principal Investigator - Kenneth Sherman, MD, PhD
University of Cincinnati
Principal Investigator - Michael Adler, MD, PhD
Erasmus Hospital Bruxelles
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
82 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Ghent, Belgium
- Facility name not stated
Liège, Belgium
- Facility name not stated
Amsterdam, Netherlands
- Facility name not stated
Amsterdam, Netherlands
- Facility name not stated
Arnhem, Netherlands
- Facility name not stated
Santurce, Puerto Rico
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Fresno, California, United States
- Facility name not stated
La Jolla, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Sacramento, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Aurora, Colorado, United States
- Facility name not stated
Farmington, Connecticut, United States
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Gainesville, Florida, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
Orlando, Florida, United States
- Facility name not stated
Sarasota, Florida, United States
- Facility name not stated
Wellington, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Marietta, Georgia, United States
- Facility name not stated
Honolulu, Hawaii, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Downers Grove, Illinois, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
New Orleans, Louisiana, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Hyattsville, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2008
- Primary completion
- 30 Jun 2010
- Completion
- 31 Jul 2010
- Last update posted
- 26 Mar 2021
- Registered enrollment
- 540
- Registry id
- NCT00758043
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.